Global 23-Valent Pneumococcal Polysaccharide Vaccine Market to Reach 4550 million USD by 2025 says a Latest Research Report
Jun 13, 2018
This report studies the global 23-Valent Pneumococcal Polysaccharide Vaccine market status and forecast, categorizes the global 23-Valent Pneumococcal Polysaccharide Vaccine market size (value & volume) by manufacturers, type, application, and region.
Pune, India - June 13, 2018 /MarketersMedia/ —
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months. North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
Access more report details at: https://www.themarketreports.com/report/global-23-valent-pneumococcal-polysaccharide-vaccine-market-research-report-2018
Key companies profiled in this report are MSD, Sanofipasteur, CDIBP and others in terms of Company Basic Information, Manufacturing Base, Sales Area, Competitors, Product Category, Application, Specification, Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
The study objectives of this report are:
• To analyze and study the global 23-Valent Pneumococcal Polysaccharide Vaccine sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/984978
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Single Dose Vial
• Pre-filled Syringe
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• For Children (2-10)
• For Person (10-64)
• For The Old (≥65)
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/984978
Contact Info:
Name: Shirish Gupta
Email: [email protected]
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
For more information, please visit https://www.themarketreports.com/report/global-23-valent-pneumococcal-polysaccharide-vaccine-market-research-report-2018
Source: MarketersMedia
Release ID: 359614
More News
NTF-Elcac scores groups criticizing BDP projects in Iloilo
MANILA, Philippines – The National Task Force to End Local Communist Armed Conflict (NTF-Elcac) has scored the “hypocrisy” of groups claiming to champion the poor while allegedly discrediting Iloilo’s Barangay Development Program (BDP). This came after Bayan-Panay, in a statement issued on Oct. 15, cited the Commission on Audit’s (COA) 2025 audit report on the
Kehlani live in Manila: Here are the ticket prices
Ticket details for Kehlani's upcoming concert at the SM Mall of Asia Arena on February 15, 2027 have been released.
/file/attachments/orphans/ZahidHamidi1_597968.png)
Court grants stay in M'sian Bar's challenge over Zahid case
Judge gives decision in chamber proceedings, lawyer says.
Rosal slightly accelerates; signal No. 1 still up in 6 areas
MANILA, Philippines — Tropical Cyclone Wind Signal No. 1 (TCWS) remained hoisted over six areas in northern and southern Luzon as Super Typhoon Rosal (international name: Champi) slightly accelerated over east of northern Luzon on Wednesday morning, according to the state weather bureau. In the 5 a.m. weather bulletin of the Philippine Atmospheric, Geophysical, and Astronomical
House panel summons DILG's Remulla, PDEA's Nerez over attempted Laos drugs shipment
The House Committee on Dangerous Drugs has summoned Interior and Local Government Secretary Jonvic Remulla and Philippine Drug Enforcement Agency (PDEA) Director General Undersecretary Isagani Nerez over the attempted shipment of illegal drugs from Laos.
Malaysia bans civil servants from using mapping app Waze, citing links to Israel
Prime Minister Anwar Ibrahim recommends the use of TuJu, a domestic mapping app developed by the Malaysian Highway Authority, as an alternative
Atong Ang out of PH? DOJ chief cannot confirm
Justice Secretary Fredderick Vida on Wednesday said he cannot confirm reports that businessman Atong Ang, the alleged mastermind in the disappearance of several sabungeros, has left the country.
5 ways to heal from a friendship breakup
If you’re navigating the grief and fallout of a difficult friendship breakup, here are a few ways to get by
New reality series helps Filipinos address skin conditions
“Kutis Reveal” follows 12 Filipinos through five months of consultations and treatment—hoping to improve not just their skin but also their confidence and quality of life
De Lima, Diokno, 8 other House lawmakers want China envoy recalled
The lawmakers say the President must 'take decisive action in response to statements and conduct that undermine national sovereignty and threaten the country's security'
Expectation vs. reality: Online seller's Chinese-style shirt ends up on horror character on 'Unang Hirit'
An online seller who posted his Chinese-style shirt on Facebook Marketplace got an unexpected surprise after finding out who actually wore the outfit.
Musk says SpaceX-Tesla merger is ‘a good idea’ as companies form deal committees
'I think it would be a good idea, but it's really up to the special committees of both companies,' Elon Musk says in the first official confirmation that the companies were formally talking
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.